Explore Publications

On the eve of opening a new auto factory in West Bengal, arranged via secret contract with the government, Indian industrial giant Tata is facing massive protests by local farmers determined not to be pushed off their land.

Globally, Toyota is known for its innovation and quality of products like the Prius hybrid. A closer look at operations in Japan, the Philippines, Myanmar and the U.S. reveals a story of extreme working conditions, union-busting and other corporate abuses. In Japan and elsewhere, workers are speaking out.

Two Chevron Corp. lawyers fighting a landmark pollution lawsuit in Ecuador have been indicted by that country's prosecutor general, a move the company says proves the government is trying to tamper with the suit.

Employees of the federal agency that last year collected more than $11 billion in royalties from oil and gas companies broke government rules and created a "culture of ethical failure" by allegedly accepting gifts from and having sex with industry representatives, the Interior Department's top watchdog said Wednesday.

Former UnitedHealth Group Inc. Chief Executive William McGuire agreed to pay $30 million and forfeit 3.7 million stock options to settle shareholder claims related to options backdating, adding to what was already one of the largest executive-pay givebacks in history.

The U.S. government on Tuesday said it had approved up to $330 million in three separate arms deals for Israel, and sources tracking a much bigger deal for 25 Lockheed Martin Corp F-35 fighter jets said that agreement could be approved later this month.

A federal judge in Brooklyn decided on Friday to unseal confidential materials about Eli Lilly's top-selling antipsychotic drug Zyprexa, citing "the health of hundreds of thousands of people" and "fundamental questions" about the way drugs are approved for new uses.

The US military provided combat training to 80 Georgian special forces commandos only months prior to Georgia's army assault in South Ossetia in August.

About the only point on which both sides agree is that no one can judge ezetimibe's safety and benefits for certain without more data, ideally from a clinical trial covering more than 10,000 patients and lasting several years, long enough to show that the drug actually helps patients live longer or avoid heart attacks.

Multinational industries like tobacco and alcohol have responded to increased global public pressure for accountability around corporate operations by creating Voluntary Codes of Conduct to self-regulate their behavior. But how are the results measuring up?